Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postprandial glycemic response of Glucomeal in type 2 diabetes
TCTR20190917004Phase 0Completed
- Sponsor
- Mega Lifesciences
- Start
- Aug 2019
- Countries
- 1
01
Overview
Phase 0 trial in type 2 diabetes mellitus (T2DM), sponsored by Mega Lifesciences. Primary endpoint: Postprandial glycemic response. Started Aug 2019; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20190917004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190917004.